Rheumatologists have been urged to avoid complacency with regards to the long-term use of glucocorticoids in systemic lupus erythematosus. Up to 80% of lupus patients are exposed to glucocorticoids despite increasing evidence of their risks, according to a review published recently in Rheumatology. Co-author Dr Diane Apostolopoulos, from the School of Clinical Sciences at Monash ...
More effort urged on steroid-sparing approach to lupus
By Mardi Chapman
13 Feb 2017